YU42401A - Supstituisani heterociklični acil-tripeptidi korisni kao modulatori receptora trombina - Google Patents

Supstituisani heterociklični acil-tripeptidi korisni kao modulatori receptora trombina

Info

Publication number
YU42401A
YU42401A YU42401A YU42401A YU42401A YU 42401 A YU42401 A YU 42401A YU 42401 A YU42401 A YU 42401A YU 42401 A YU42401 A YU 42401A YU 42401 A YU42401 A YU 42401A
Authority
YU
Yugoslavia
Prior art keywords
thrombin receptor
acyl
substituted
receptor modulators
heterociclic
Prior art date
Application number
YU42401A
Other languages
English (en)
Inventor
F. David McComsey
E. Bruce Maryanoff
J. Michael Hawkins
Original Assignee
Ortho-Mcneil Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho-Mcneil Pharmaceuticals Inc. filed Critical Ortho-Mcneil Pharmaceuticals Inc.
Publication of YU42401A publication Critical patent/YU42401A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Pronalazak se odnosi na supstituisane heterociklične acil-tripeptide korisne kao modulatori trombin receptora, njihovu upotrebu u lečenju rana i sprečavanju agregacije krvnih pločica. Takodje su otkrivene i farmaceutske kompozicije koje sadrže supstituisane heterociklične acil-tripeptide prema ovom pronalasku i metode za lečenje stanja u kojima posreduje receptor trombina.[The invention is directed to substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators, their use in wound healing and preventing platelet aggregation. Pharmaceutical compositions comprising the substituted heterocyclic acyl-tripeptides of the present invention and methods of treating conditions mediated by the thrombin receptor are also disclosed.
YU42401A 1998-12-14 1998-12-14 Supstituisani heterociklični acil-tripeptidi korisni kao modulatori receptora trombina YU42401A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11231398P 1998-12-14 1998-12-14
US44432799A 1999-11-19 1999-11-19

Publications (1)

Publication Number Publication Date
YU42401A true YU42401A (sh) 2003-12-31

Family

ID=26809819

Family Applications (1)

Application Number Title Priority Date Filing Date
YU42401A YU42401A (sh) 1998-12-14 1998-12-14 Supstituisani heterociklični acil-tripeptidi korisni kao modulatori receptora trombina

Country Status (13)

Country Link
US (2) US6747127B1 (sh)
EP (1) EP1140985A1 (sh)
CN (1) CN1342164A (sh)
AU (1) AU771844B2 (sh)
BR (1) BR9916811A (sh)
CA (1) CA2355818A1 (sh)
CZ (1) CZ20012136A3 (sh)
HU (1) HUP0104588A3 (sh)
NO (1) NO20012939L (sh)
PL (1) PL348504A1 (sh)
TR (1) TR200102502T2 (sh)
WO (1) WO2000035942A1 (sh)
YU (1) YU42401A (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20060159663A1 (en) * 2004-07-30 2006-07-20 Lu Helen H Growth factor encapsulation system for enhancing bone formation
US20060293231A1 (en) * 2004-07-30 2006-12-28 Regina Landesberg Method for enhancing bone formation
US8097582B2 (en) 2006-05-09 2012-01-17 Neobiotics Ab Peptide derivatives useful as antimicrobial agents and for treating wounds
JP5296688B2 (ja) 2006-09-11 2013-09-25 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 殺虫化合物
CN101747410B (zh) * 2008-11-28 2013-03-13 北京大学 具镇痛活性的氨基酰酪氨酰色氨酸三肽及制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL60888A (en) 1978-06-16 1984-07-31 Yeda Res & Dev Substrates and process for the quantitative assay of enzymes
GB9019558D0 (en) 1990-09-07 1990-10-24 Szelke Michael Enzyme inhibitors
US5391705A (en) 1991-03-15 1995-02-21 Merrell Dow Pharmaceuticals Inc. Polyfluorinated tripeptide thrombin inhibitors
EP0503203A1 (en) 1991-03-15 1992-09-16 Merrell Dow Pharmaceuticals Inc. Novel thrombin inhibitors
HU221974B1 (hu) 1992-06-04 2003-03-28 Merrell Dow Pharmaceuticals Inc. Eljárás trombingátló hatású fluortartalmú peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5696231A (en) 1994-12-21 1997-12-09 Corvas International, Inc. N-substituted glycine derivatives as enzyme inhibitors
US6069232A (en) 1995-10-02 2000-05-30 Hoechst Marion Roussel, Inc. Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
US6017890A (en) 1998-02-19 2000-01-25 Ortho-Mcneil Pharmaceutical, Inc. Azole peptidomimetics as thrombin receptor antagonists
DE69902887T2 (de) * 1998-02-19 2003-08-07 Ortho-Mcneil Pharmaceutical, Inc. Azole peptidomimetische verbindungen als thrombin rezeptor antagoniste

Also Published As

Publication number Publication date
AU1825600A (en) 2000-07-03
BR9916811A (pt) 2002-01-15
CZ20012136A3 (cs) 2002-02-13
AU771844B2 (en) 2004-04-01
EP1140985A1 (en) 2001-10-10
NO20012939D0 (no) 2001-06-14
WO2000035942A1 (en) 2000-06-22
US20040063903A1 (en) 2004-04-01
CA2355818A1 (en) 2000-06-22
HUP0104588A2 (hu) 2002-04-29
US7312306B2 (en) 2007-12-25
NO20012939L (no) 2001-08-09
CN1342164A (zh) 2002-03-27
US6747127B1 (en) 2004-06-08
TR200102502T2 (tr) 2002-05-21
PL348504A1 (en) 2002-05-20
HUP0104588A3 (en) 2002-05-28

Similar Documents

Publication Publication Date Title
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
AU1244001A (en) Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
ATE376835T1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
NO991732L (no) Nye heterocyklylmetylsubstituerte pyrazolderivater
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
DE60122767D1 (de) Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns
ATE269113T1 (de) Sprühfähige wundversorgungszusammensetzung
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
EP1244452A4 (en) UROTENSIN II RECEPTOR ANTAGONISTS
ATE219073T1 (de) Benzopyran derivate mit leukotrien- antagonistischer wirkung
IL152450A (en) Compounds and compositions for use in treating tnf-?? mediated conditions
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
PT684816E (pt) Composicoes antagonistas do receptor da 5-ht2 uteis no tratamento de doencas venosas
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
UY26426A1 (es) Nuevos compuestos
YU42401A (sh) Supstituisani heterociklični acil-tripeptidi korisni kao modulatori receptora trombina
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
EP1806356A3 (en) Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators
MXPA02002007A (es) Compuestos de bencimidazol sustituidos con alcoxi, preparaciones farmaceuticas que contienen los mismos, metodos para usarlos.
DE69326349D1 (de) Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen